Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pomegranate peel aqueous extract is a botanical preparation derived from the fruit husks of *Punica granatum*. It is characterized by a high concentration of bioactive polyphenols, including hydrolyzable tannins such as punicalagin, as well as flavonoids and phenolic acids. In preclinical models, the extract has demonstrated significant antioxidant, anti-inflammatory, and immunomodulatory activities. It works by scavenging free radicals and downregulating pro-inflammatory mediators, including TNF-α, NF-κB, and iNOS. Research has explored its potential in protecting against selenite-induced cataracts, toluene-induced hepatotoxicity, and intestinal mucosal damage. Additionally, it has shown scolicidal activity against *Echinococcus granulosus*, particularly when used as an adjunct to standard anthelmintic therapy like albendazole.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pomegranate peel aqueous extract.